Insider Transactions in Q1 2025 at Ardelyx, Inc. (ARDX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 20
2025
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,171
-1.78%
|
$25,855
$5.62 P/Share
|
|
Feb 20
2025
|
Laura A Williams Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,941
-1.6%
|
$24,705
$5.62 P/Share
|
|
Feb 20
2025
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
4,291
-2.32%
|
$21,455
$5.62 P/Share
|
|
Feb 20
2025
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
22,964
-2.07%
|
$114,820
$5.62 P/Share
|
|
Jan 31
2025
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
41,666
-3.62%
|
$208,330
$5.36 P/Share
|
|
Jan 31
2025
|
Michael Raab President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,833
+1.78%
|
$0
$0.99 P/Share
|
|
Jan 21
2025
|
David M Mott Director |
BUY
Open market or private purchase
|
Direct |
199,000
+9.31%
|
$796,000
$4.99 P/Share
|
|
Jan 16
2025
|
Richard J Rodgers Director |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+22.2%
|
$0
$0.55 P/Share
|
|
Jan 07
2025
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
41,666
-3.56%
|
$208,330
$5.31 P/Share
|
|
Jan 07
2025
|
Michael Raab President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,833
+1.75%
|
$0
$0.99 P/Share
|